BioSpace News Archive

Policy

Clovis Oncology Receives EMA Validation for its Application for a New Indication for Rubraca®▼ (rucaparib) as Maintenance Treatment for Women with Recurrent Ovarian Cancer

The filing is based on positive phase 3 ARIEL3 clinical trial data in which rucaparib significantly improved progression free survival (PFS) compared to placebo in all primary efficacy ovarian cancer patient populations

July 5, 2018
·
10 min read
Genetown

Homology Medicines to Present at the National PKU Alliance Conference

Homology Medicines, Inc. announced that it will present data from its phenylketonuria (PKU) gene therapy program and will participate on a panel on emerging therapies at the National PKU Alliance (NPKUA) Conference July 5-8, 2018 at the Hilton Downtown Atlanta.

July 5, 2018
·
5 min read
Deals

Boston Scientific to Acquire Cryterion Medical, Inc.

Company to expand atrial fibrillation ablation therapy offerings with innovative cryoballoon platform

July 5, 2018
·
8 min read
Business

ContraVir Pharmaceuticals to Present at Virtual Investor Conference

Live Webcast Scheduled for July 12, 2018, 10:00 AM ET, followed by Q&A

July 5, 2018
·
2 min read
Business

Medical Marijuana, Inc. and Subsidiaries Announce June 2018 as the Largest Sales Month in Company History

Medical Marijuana, Inc. announced that both the Company and its subsidiaries Kannaway® and HempMeds® Mexico have booked their largest-ever (unaudited) sales in their history in June of 2018, as well as reached major milestones in business operations.

July 5, 2018
·
3 min read
Sisram Lays Out a Post-IPO Vision of Becoming Global MedTech Leader

Sisram Medical Ltd has laid out its vision to become a global MedTech leader leveraging its solid funding channels, strong R&D capabilities and comprehensive portfolio of products.

July 5, 2018
·
3 min read
Deals

RPM Declares Quarterly Dividend of $0.32 Per Share

RPM International Inc. announced that its board of directors has declared a regular quarterly cash dividend of $0.32 per share, payable on July 31, 2018 to stockholders of record as of July 17, 2018.

July 5, 2018
·
2 min read
Seoul Viosys Applies UV LED Technology ‘Violeds’ to Mosquito Trap Not Containing Chemical Components

Seoul Viosys announced that it has applied its advanced UV LED technology “Violeds” to mosquito trap of Yuhan Corporation, a pharmaceutical company in Korea.

July 5, 2018
·
2 min read
Genetown

Orig3n Introduces New Run™ DNA Test

Test Offers Insight into Training Style and Nutritional Needs

July 5, 2018
·
2 min read
Business

NanoSphere Health Sciences To Report Revenue and Significant Sales Growth in Second Quarter

Biotech leader increases cannabis brand sales in Colorado by 35 percent ahead of California launch

July 5, 2018
·
5 min read